Next 10 |
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to ...
Citius Pharmaceuticals to Host Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution PR Newswire Management call scheduled for Monday, June 3, 2024 at 8:30 AM ET CRANFORD, N.J. , May 29, 2024 /PRNewswire/ -...
2024-05-21 11:42:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Yogi Tea recalls are in effect for some of the company’s tea bags over concerns of high amounts of pesticide residue that may be found in them. This has Yogi Tea recalling almo...
2024-05-21 11:20:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips VinFast Auto (NASDAQ: VFS ) stock is on the move and falling hard on Tuesday after the company confirmed its under investigation by the National Highway Traffic Safety Administratio...
2024-05-21 10:58:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Citius Pharmaceuticals (NASDAQ: CTXR ) stock is on the rise Tuesday after the company announced new results from its Phase 3 clinical trial of Mino-Lok . Mino-Lok is Citius ...
2024-05-21 09:43:10 ET More on Citius Pharmaceuticals Seeking Alpha’s Quant Rating on Citius Pharmaceuticals Historical earnings data for Citius Pharmaceuticals Financial information for Citius Pharmaceuticals Read the full article on Seeking Alpha ...
Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution PR Newswire Trial achieves statistically significant primary endpoint (p=0.0006) Secondary endpoint demonstrates statistically significant overall succ...
Citius Pharmaceuticals (NASDAQ: CTXR) is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The company's diversified pipeline includes two late-stage product candidates. At the end of 2023, Citius completed enrollm...
2024-05-14 17:03:43 ET More on Citius Pharmaceuticals Seeking Alpha’s Quant Rating on Citius Pharmaceuticals Historical earnings data for Citius Pharmaceuticals Financial information for Citius Pharmaceuticals Read the full article on Seeking Alpha ...
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update PR Newswire Mino-Lok data analysis on track with topline results anticipated this quarter LYMPHIR biologics license application accepted with PDUFA target action da...
News, Short Squeeze, Breakout and More Instantly...
Citius Pharmaceuticals Inc. Company Name:
CTXR Stock Symbol:
NASDAQ Market:
Citius Pharmaceuticals Inc. Website:
NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to ...
Citius Pharmaceuticals to Host Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution PR Newswire Management call scheduled for Monday, June 3, 2024 at 8:30 AM ET CRANFORD, N.J. , May 29, 2024 /PRNewswire/ -...